Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-10

FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved a new original application for a fixed-dose combination eye drop of brimonidine tartrate and timolol maleate for lowering intraocular pressure in o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brimonidine tartrate and timolol maleate (brimonidine tartrate and timolol maleate)

Snippet

ORIG AP for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE (BRIMONIDINE TARTRATE AND TIMOLOL MALEATE)